Skip to main
CUVL

CUVL Market Capitalization Overview

Market Cap: $373.04M as of Jul 20, 2026

$373.04M
$2.02M (0.54%)past month
As of Jul 20, 2026, CUVL has a market capitalization of $373.04M. Over the past 30 days, its market cap has increased by 5.76%, while in the last 12 months, it has decreased by -12.34%.

Market capitalization represents the total value of Clinuvel Pharmaceuticals Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

CUVL Market Cap Formula = Stock Price * Shares Outstanding

The market cap of CUVLhelps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CUVL Market Cap History

DateMarket CapChange
Jul 1, 2026$370.52M+5.76%
Jun 1, 2026$350.36M+3.73%
May 1, 2026$337.76M-7.04%
Apr 1, 2026$363.33M-2.36%
Mar 2, 2026$372.12M-5.54%
Feb 2, 2026$393.95M-3.33%
Jan 2, 2026$407.50M+6.14%

CUVL End of Year Market Cap History

DateMarket CapChange
2026$373.04M-12.34%
2025$425.56M+10.40%
2024$385.47M-30.44%
2023$554.16M-23.89%
2022$728.07M-25.99%
2021$983.76M

FAQs About Clinuvel Pharmaceuticals Ltd (CUVL) Market Cap

As of Jul 20, 2026, the market capitalization of CUVL is $373.04M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Clinuvel Pharmaceuticals Ltd’s market capitalization has increased by 0.5400%, changing from $371.03M to $373.04M as of Jul 20, 2026.

In the last 3 months, Clinuvel Pharmaceuticals Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Clinuvel Pharmaceuticals Ltd’s market capitalization increased from $385.47M in January to $425.56M in December, reflecting a 10.4% change.

In the past five years, CUVL has had a compound annual growth rate (CAGR) of -15.43% in market capitalization. This means its market cap has shrunk at an average rate of -15.43% per year.

Clinuvel Pharmaceuticals Ltd (CUVL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.